IRadimed Corp reports results for the quarter ended in March - Earnings Summary

IRADIMED

02/05/2024 16:14

* IRadimed Corp  IRMD.OQ  reported quarterly adjusted
earnings of
36 cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of 30
cents.  The mean expectation of two analysts for the quarter was
for earnings of 34 cents per share. Wall Street expected
results to range from 33 cents to 34 cents per share.
    * Revenue rose 13.7% to $17.60 million from a year ago;
analysts
expected $17.13 million. 
    * IRadimed Corp's reported EPS for the quarter was 32
cents​.
    * The company reported quarterly net income of $4.14
million.
    * IRadimed Corp shares had fallen by 4.5% this quarter and
lost 11.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 18.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for IRadimed Corp is
$62.50 
This summary was machine generated from LSEG data May 2 at 03:13
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.34           0.36           Beat
 Dec. 31 2023      0.40           0.39           Missed
 Sep. 30 2023      0.36           0.43           Beat
 Jun. 30 2023      0.31           0.36           Beat